Skip to main content Accessibility help
×
Hostname: page-component-6b989bf9dc-pmhlf Total loading time: 0 Render date: 2024-04-13T03:35:33.677Z Has data issue: false hasContentIssue false

14 - Treatment of Ovarian Hyperstimulation Syndrome

Published online by Cambridge University Press:  31 March 2017

Botros Rizk
Affiliation:
University of South Alabama
Jan Gerris
Affiliation:
Universiteit Gent, Belgium
Get access
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Rizk, B, Smitz, J. Ovarian hyperstimulation syndrome after superovulation for IVF and related procedures. Hum Reprod 1992;7:320–27.Google Scholar
Rizk, B. Ovarian hyperstimulation syndrome. In: Studd, J, ed. Progress in Obstetrics and Gynecology. Edinburgh: Churchill Livingstone, 1993; Chapter 11, pp. 311–49.Google Scholar
Rizk, B, Rizk, C B, Nawar, M G, Garcia-Velasco, J A, Sallam, H N. Ultrasonography in the prediction and management of ovarian hyperstimulation syndome In: Rizk, B, ed. Ultrasonography in Reproductive Medicine and Infertility. Cambridge: Cambridge University Press, 2010, Chapter 36, pp. 299312.CrossRefGoogle Scholar
Serour, G I, Aboulghar, M A, Mansour, R, et al. Complications of medically assisted conception in 3,500 cycles. Fertil Steril 1998;70:638–42.Google Scholar
Mathur, R S, Akande, A V, Keay, S D, et al. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 2000;73:901–07.Google Scholar
Aboulghar, M A, Mansour, R T. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 2003;9:275–89.CrossRefGoogle ScholarPubMed
Rizk, B, Aboulghar, M A. Classification, pathophysiology and management of ovarian hyperstimulation syndrome. In: Brinsden, P, ed. A Textbook of In-vitro Fertilization and Assisted Reproduction, Second Edition. Carnforth: The Parthenon Publishing Group, 1999, Chapter 11, pp. 131–55.Google Scholar
Rizk, B, Aboulghar, M A, Smitz, J, RonEl, R. The role of vascular endothelia growth factor and interleukins in the pathogenesis pf severe ovarian hyperstimulation syndrome Hum Reprod Update 1997;3:255–66.Google Scholar
Pellicer, A, Albert, C, Mercader, A, et al. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin 1-β, interleukin-6 and vascular endothelial growth factor. Fertil Steril 1999;71:482–89.Google Scholar
Rizk, B. Ovarian Hyperstimulation Syndrome: Epidemiology, Pathophysiology, Prevention and Management. Cambridge: Cambridge University Press, 2006.Google Scholar
Rizk, B, Aboulghar, M. Modern management of ovarian hyperstimulation syndrome. Hum Reprod 1991;6:1082–87.Google ScholarPubMed
Delvigne, A, Rozenberg, S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 2002;8:559–77.Google Scholar
.Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril 2003;80:1309–14.Google Scholar
Rizk, B. Prevention of ovarian hyperstimulation syndrome: the Ten Commandments. Presented at the 1993 European Society of Human Reproduction and Embryology Symposium, Tel Aviv, Israel, 1993, 12.Google Scholar
Al-Inany, H, Aboulghar, M A, et al. Gonadotropin-releasing hormone antagonists in assisted reproduction: a Cochrane review. Hum Reprod 2002;17:874–85.Google Scholar
Ludwig, M, Katalinic, A, Diedrich, K. Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis. Arch Gynecol Obstet 2001;265:175–82.Google Scholar
Al-Inany, H G, Abou-Setta, A M, Boulghar, M. Gonadotropin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev 2011;(5):CD001750.Google Scholar
Kolibianakis, E M, Collins, J, Tarlatzis, B C, et al. Among patients treated for IVF with gonadotropins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 2006;12:651–71.Google Scholar
Rizk, B. Coasting for the prevention of critical OHSS: an American perspective In: Gerris, J, Olivennes, F, Delvigne, A, eds. Ovarian Hyperstimulation Syndrome. Taylor and Francis, 2006; Chapter 23, pp. 247–67.Google Scholar
Rizk, B. Prevention and management of ovarian hyperstimulation syndrome. Curr Women’s Health Rev 2010;6(2):130–45.Google Scholar
Abdalla, H I, Ahmoye, N M, Brinsden, P, et al. The effect of the dose of human chorionic gonadotrophin and the type of gonadotrophin stimulation on oocyte recovery rates in an in-vitro fertilization program. Fertil Steril 1987; 48:958–63.Google Scholar
Tsoumpou, I, Muglu, J, Gelbaya, T A, Nardo, L G. Optimal dose of hCG for final oocyte maturation in IVF cycles: absence of evidence. Reprod Biomed Online 2009;19(1):5258.Google Scholar
Griesinger, G, Diedrich, K, Devroey, P, et al. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update 2006;12:159–68.Google Scholar
Aboulghar, M, Evers, J H, Al-Inany, H. Intravenous albumin for preventing severe ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 2000;2:CD001302.Google Scholar
Rizk, B, Aboulghar, M A, Mansour, R T, et al. Severe ovarian hyperstimulation syndrome: analytical study of twenty-one cases. Proceedings of the VII World Congress on In-vitro Fertilization and Assisted Precreations, Paris. Hum Reprod 1991:368–69.Google Scholar
Tang, T, Glanville, J, Orsi, N, et al. The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod 2006;21:1416–25.Google Scholar
Moll, E, van der Veen, F, van Wely, M. The role of metformin in polycystic ovary syndrome: a systematic review. Hum Reprod Update 2007;13:527–37.Google Scholar
Alvarez, C, Marti-Bonmati, L, Novella-Maestre, E. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab 2007;92:2931–37.Google Scholar
Alvarez, C, Alonso-Muriel, I, Garcia, G, et al. Implantation is apparently unaffected by the dopamine agonist cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study. Hum Reprod 2007;22:3210–14.Google Scholar
Busso, C E, Garcia-Velasco, J A, Gomz, R, et al. Ovarian hyperstimulation syndrome. In: Rizk, B, Garcia-Velasco, J A, Sallam, H N, Makrigiannakis, A, eds. Infertility and Assisted Reproduction. Cambridge: Cambridge University Press, 2008; Chapter 27, pp. 243–57.Google Scholar
Busso, C, Fernandez-Sanchez, M, Garcia-Velasco, J A, et al. Quinagolide is effective in preventing moderate/severe early OHSS in IVF patients: a randomized, double blind, placebo, controlled trial. The 24th Annual Mtg of the European Society of Reproduction and Embryology, 6–9 July, Barcelona, Spain, 2008;41(abstract).Google Scholar
Busso, C E. Prevention of OHSS-dopamine agonists. Reproductive Biomed Online 2009;19(1):4351.Google Scholar
D’Angelo, A, Amso, N. Embryo freezing for preventing ovarian hyperstimulation syndrome: a Cochrane review. Hum Reprod 2002;17:2787–94.Google Scholar
Son, W Y, Yoon, S H, Lim, J H. Effect of gonadotropin priming on in-vitro maturation of oocytes collected from women at risk of OHSS. Reprod Biomed Online 2006;13:340–48.Google Scholar
Son, W Y, Yoon, S H, Lee, S W, et al. Blastocyst development and pregnancies after IVF of mature oocytes retrieved from unstilulated patients with PCOS after in-vivo hCG priming. Hum Reprod 2002;17:134–36.Google Scholar
Abramov, Y, Fatum, M, Abrahomov, D, et al. Hydroxyethyl starch versus human albunin for the treatment of severe ovarian hyperstimulation syndrome: a prelinimary report. Fertil Steril 2001;75:1228–30.Google Scholar
Gamzu, R, Almog, B, Levin, Y, et al. Efficacy of hydroxyethyl starch and haemaccel for the treatment of severe ovarian hyperstimulation syndrome. Fertil Steril 2002;77:1302–03.CrossRefGoogle ScholarPubMed
Rizk, B, Meagher, S, Fisher, A M. Ovarian hyperstimulation syndrome and cerebrovascular accidents. Hum Reprod 1990;5:697–98.Google Scholar
Brinsden, P R, Wada, I, Tan, S L, et al. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995;102:767–72.Google Scholar
Fabregues, F, Tassies, D, Reverter, J C, et al. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening. Fertil Steril 2004;81:989–95.Google Scholar
Mikhail, S, Rizk, R M B, Nawar, M G, Rizk, C B. Thrombophilia and implantation failure. In: Rizk, B, Garcia-Velasco, J A, Sallam, H N, Makrigiannakis, A, eds. Infertility and Assisted Reproduction. Cambridge: Cambridge University Press, 2008; Chapter 45, pp. 407–15.Google Scholar
Aboulghar, M A, Mansour, R T, Serour, G I, et al. Ultrasonically guided vaginal aspiration of ascites in the treatment of ovarian hyperstimulation syndrome. Fertil Steril 1990;53:933–35.Google Scholar
Aboulghar, M A, Mansour, R T, Serour, G I, et al. Autotransfusion of the ascitic fluid in the treatment of severe ovarian hyperstimulation syndrome (OHSS). Fertil Steril 1992;58:1056–59.Google Scholar
Ferraretti, A P, Gianaroli, L, Diotallevi, L, et al. Dopamine treatment for severe hyperstimulation syndrome. Hum Reprod 1992; 7:180–83.Google Scholar
Tsunoda, T, Shibahara, H, Hirano, Y, et al. Treatment of ovarian hyperstimulation syndrome using an oral dopamine prodrug, docarpamine. Gynecol Endocrinol 2003;17:281–86.Google Scholar
Rizk, B. Complications of ovulation induction II: ovarian hyperstimulation syndrome, ovarian torsion. In: Dickey, R P, Brinsden, P R, Pyrzak, R, eds. Manual of Intrauterine Insemination and Ovulation Induction. Cambridge: Cambridge University Press, 2010; Chapter 15, pp. 152–60.Google Scholar
Eyvazzadeh, A D, Ryley, D A, Khachadoorian, H R, Alper, M M, Reindollar, R H. Adnexal torsion: a review of 80 cases. Fertil Steril 2005;84(Suppl 1):S164–65.Google Scholar
Aboulghar, M. Prevention of OHSS. RBM Online 2009;19(1):3342.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×